spiperone has been researched along with remoxipride in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cleves, AE; Jain, AN; Kirshner, D; Langham, JJ; Spitzer, R | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| de Paulis, T; Hall, H; Högberg, T; Johansson, L; Kumar, Y; Ogren, SO | 1 |
| Hall, H; Jerning, E; Sällemark, M | 1 |
| Hall, H; Sällemark, M | 1 |
| Angeby, K; Florvall, L; Hall, H; Köhler, C; Lindbom, LO; Magnusson, O; Ogren, SO | 1 |
| Högberg, T; Jackson, DM; Malmberg, A; Mohell, N; Rosqvist, S; Sällemark, M | 1 |
7 other study(ies) available for spiperone and remoxipride
| Article | Year |
|---|---|
Physical binding pocket induction for affinity prediction.
Topics: Binding Sites; Ligands; Models, Molecular; Neural Networks, Computer; Peptide Fragments; Protein Binding; Receptor, Serotonin, 5-HT1A | 2009 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Potential antipsychotic agents. 7. Synthesis and antidopaminergic properties of the atypical highly potent (S)-5-bromo-2,3-dimethoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]benzamide and related compounds. A comparative study.
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Benzamides; Chemical Phenomena; Chemistry; Corpus Striatum; Dopamine Antagonists; Hydrogen Bonding; Male; Molecular Structure; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Remoxipride; Salicylamides; Spiperone; Structure-Activity Relationship | 1990 |
Effects of remoxipride and some related new substituted salicylamides on rat brain receptors.
Topics: Adenylyl Cyclases; Animals; Antipsychotic Agents; Apomorphine; Benzamides; Brain; Domperidone; Dopamine; In Vitro Techniques; Male; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Neurotransmitter; Receptors, Serotonin; Remoxipride; Salicylamides; Spiperone; Structure-Activity Relationship; Tetrahydronaphthalenes; Tritium | 1986 |
Effects of chronic neuroleptic treatment on agonist affinity states of the dopamine-D2 receptor in the rat brain.
Topics: Animals; Antipsychotic Agents; Benzamides; Binding, Competitive; Brain Chemistry; Guanylyl Imidodiphosphate; Kinetics; Male; Raclopride; Rats; Rats, Inbred Strains; Receptors, Dopamine; Remoxipride; Salicylamides; Spiperone | 1987 |
Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain.
Topics: Adenylyl Cyclases; Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Benzamides; Binding, Competitive; Brain Chemistry; Catalepsy; Chlorpromazine; Dogs; Female; Haloperidol; Histocytochemistry; Humans; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Remoxipride; Spiperone; Sulpiride; Thioridazine; Vomiting | 1984 |
Binding characteristics of remoxipride and its metabolites to dopamine D2 and D3 receptors.
Topics: Animals; Cell Line; Cloning, Molecular; Corpus Striatum; Fibroblasts; Humans; Mice; Raclopride; Radioligand Assay; Rats; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Remoxipride; Salicylamides; Spiperone | 1993 |